Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia

References

• Amelink M, de Groot JC, de Nijs SB, Lutter R, Zwinderman AH, Sterk PJ, ten Brinke A, Bel EH. Severe adult-onset asthma: a distinct phenotype. J Allergy Clin Immunol. 2013;132:336–341. doi:10.1016/j.jaci.2013.04.052. PMID:23806634.
   PubMed Web of Science ®Google Scholar
• Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol. 2015;135:299–310. doi:10.1016/j.jaci.2014.12.1871. PMID:25662302.
   PubMed Web of Science ®Google Scholar
• de Groot JC, ten Brinke A, Bel EHD. Management of the patient with eosinophilic asthma: a new era begins. Eur Respir J Open Res. 2015;1:00024–2015.
   Google Scholar
• Yilmaz İ, Terı M. Asthma management: a new phenotype-based approach using presence of eosinophilia and allergy. Allergy. 2017;72(10):1587–1589. doi:10.1111/all.13188.
   PubMed Web of Science ®Google Scholar
• Yılmaz İ, Türk M, Bahçecioğlu SN. Eosinophilic asthma with nasal polyposis march: is aspirin-exacerbated respiratory disease the last station?. J Allergy Clin Immunol Pract. 2017;5(6):1808–1809 PMID: 29122169.
   PubMed Web of Science ®Google Scholar
• Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006;118:773–786. doi:10.1016/j.jaci.2006.07.024. PMID:17030227.
   PubMed Web of Science ®Google Scholar
• Bavbek S, Yilmaz I, Celik G, Aydin O, Erkekol FÖ, Orman A, Kurt E, Ediger D, Dursun B, Abadoğlu O, et al. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey. Allergol Immunopathol (Madr). 2012;40:225–230. doi:10.1016/j.aller.2011.05.015. PMID:21889254.
   PubMed Web of Science ®Google Scholar
• Bavbek S, Dursun AB, Dursun E, Korkmaz MH, Sertkaya D, Eryılmaz A, Mısırlıgil Z. The prevalence of aspirin intolerance established by oral provocation test in patients with sinonasal polyposis and contributing factors to this prevalence in Turkey. Allergy Clin Immunol Int: J World Allergy Org. 2005;Suppl. 1:374.
   Google Scholar
• Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma, AIANE Investigators. European network on aspirin-induced asthma. Eur Respir J. 2000;16:432–436. doi:10.1034/j.1399-3003.2000.016003432.x. PMID:11028656.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380:651–659. doi:10.1016/S0140-6736(12)60988-X. PMID:22901886.
   PubMed Web of Science ®Google Scholar
• Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371:1198–1207. doi:10.1056/NEJMoa1403290. PMID:25199059.
   PubMed Web of Science ®Google Scholar
• de Groot JC, Storm H, Amelink M, de Nijs SB, Eichhorn E, Reitsma BH, Bel EH, Ten Brinke A. Clinical profile of patients with adult-onset eosinophilic asthma. ERJ Open Res. 2016;2(2). doi:10.1183/23120541.00100-2015. PMID:27730197.
   PubMedGoogle Scholar
• Yilmaz I, Turk M. What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease? Am J Respir Crit Care Med. 2017;196(9):1229–1230. doi:10.1164/rccm.201705-0892LE. PMID:28650681.
   PubMed Web of Science ®Google Scholar
• Roufosse F, Weller PF. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol. 2010;126:39–44. doi:10.1016/j.jaci.2010.04.011. PMID:20538328.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention 2017.
   Google Scholar
• Bousquet J, Mantzouranis E, Cruz AA, Aït-Khaled N, Baena-Cagnani CE, Bleecker ER, Brightling CE, Burney P, Bush A, Busse WW, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010;126(5):926–938. doi:10.1016/j.jaci.2010.07.019. PMID:20926125.
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc. 2011;86(5):427–443. doi:10.4065/mcp.2010.0392. PMID:21490181.
   PubMed Web of Science ®Google Scholar
• Stevens WW, Schleimer RP. Aspirin-exacerbated respiratory disease as an endotype of chronic rhinosinusitis. Immunol Allergy Clin North Am. 2016;36(4):669–680. doi:10.1016/j.iac.2016.06.004. PMID:27712762.
   PubMed Web of Science ®Google Scholar
• Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135(3):676–681 doi:10.1016/j.jaci.2014.08.020. PMID:25282015.
   PubMed Web of Science ®Google Scholar
• Stevens WW, Peters AT, Hirsch AG, Nordberg CM, Schwartz BS, Mercer DG, Mahdavinia M, Grammer LC, Hulse KE, Kern RC, et al. Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2017;5(4):1061–1070 doi:10.1016/j.jaip.2016.12.027. PMID:28286156.
   PubMed Web of Science ®Google Scholar
• Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372:1107–1119. doi:10.1016/S0140-6736(08)61452-X. PMID:18805339.
   PubMed Web of Science ®Google Scholar
• Bel EH. Clinical phenotypes of asthma. Curr Opin Pulm Med. 2004;10:44–50. doi:10.1097/00063198-200401000-00008. PMID:14749605.
   PubMed Web of Science ®Google Scholar
• Gauthier M, Ray A, Wenzel SE. Evolving concepts of asthma. Am J Respir Crit Care Med. 2015;192:660–668. doi:10.1164/rccm.201504-0763PP. PMID:26161792.
   PubMed Web of Science ®Google Scholar
• ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med. 2001;164:744–748. doi:10.1164/ajrccm.164.5.2011026.PMID:11549526.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178:218–224. doi:10.1164/rccm.200711-1754OC. PMID:18480428.
   PubMed Web of Science ®Google Scholar
• Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, Bachert C. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280–1289. doi:10.1111/j.1398-9995.2006.01225.x. PMID:17002703.
   PubMed Web of Science ®Google Scholar
• Pearlman AN, Chandra RK, Chang D, Conley DB, Tripathi-Peters A, Grammer LC, Schleimer RT, Kern RC. Relationships between severity of chronic rhinosinusitis and nasal polyposis, asthma, and atopy. Am J Rhinol Allergy. 2009;23:145–148. doi:10.2500/ajra.2009.23.3284. PMID:19401038.
   PubMed Web of Science ®Google Scholar
• Lin DC, Chandra RK, Tan BK, Zirkle W, Conley DB, Grammer LC, Kern RC, Schleimer RP, Peters AT. Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy. 2011;25:205–208. doi:10.2500/ajra.2011.25.3613. PMID:21819754.
   PubMed Web of Science ®Google Scholar
• Cottin V, Bel E, Bottero P, Dalhoff K, Humbert M, Lazor R, et al. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmun Rev. 2017;16(1):1–9.
   Google Scholar
• Lefèvre G, Ackermann F, Kahn JE. Hypereosinophilia with asthma and systemic (non-vasculitic) manifestations: eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome? Autoimmun Rev. 2017;16:208–209.
   Google Scholar
• Valent P, Klion AD, Horny H-P, Roufosse F, Gotlib J, Weller PF, Hellmann A, Metzgeroth G, Leiferman KM, Arock M, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012;130:607–612. doi:10.1016/j.jaci.2012.02.019. PMID:22460074.
   PubMed Web of Science ®Google Scholar
• Gotlib J. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management. Am J Hematol. 2014;89:325–337. doi:10.1002/ajh.23664. PMID:24577808.
   PubMed Web of Science ®Google Scholar
• Yılmaz İ, Türk M, Bahçecioğlu SN. Classification of eosinophilic granulomatosis with polyangiitis phenotypes and treatment based on phenotypes. Autoimmun Rev. 2017;13:30181–30187.
   Google Scholar
• Bochenek G, Kuschill-Dziurda J, Szafraniec K, Plutecka H, Szczeklik A, Nizankowska-Mogilnicka E. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. J Allergy Clin Immunol. 2014;133(1):98–103. doi:10.1016/j.jaci.2013.07.004. PMID:23993879.
   PubMed Web of Science ®Google Scholar
• Dursun AB, Woessner KA, Simon RA, Karasoy D, Stevenson DD. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol. 2008;100:420–425. doi:10.1016/S1081-1206(10)60465-6. PMID:18517072.
   PubMed Web of Science ®Google Scholar